Liminatus Pharma Raises $650,003 in Private Placement at $2.50 Per Share

Liminatus Pharma entered into a subscription agreement with a non-U.S. investor for the private placement of 260,001 shares at $2.50 per share, for gross proceeds of $650,002.50. The company expects the placement to close on or about November 20, 2026, and plans to use the net proceeds for working…